Search results for "Chronic kidney disease"
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/02/latest-updates-on-acps-priorities-initiatives.htm
1 Feb 2023
Getting to know GLP-1 receptor agonists
Choosing among glucagon-like peptide-1 (GLP-1) receptor agonists depends on many factors, such as the desired outcome and individual risks among patients.
https://immattersacp.org/archives/2023/03/getting-to-know-glp-1-receptor-agonists.htm
1 Mar 2023
New guideline offers recommendations for older patients with diabetes or prediabetes
The Endocrine Society's new clinical practice guideline recommends lifestyle therapy, then metformin, then second-line drugs (but not sulfonylureas and glinides) or insulin for diabetes patients ages 65 years and older, among other advice.
https://immattersacp.org/weekly/archives/2019/04/02/1.htm
2 Apr 2019
Benefits, harms of osteoporosis medications unclear for patients with CKD
Among several gaps in medical knowledge, there was conflicting or insufficient evidence of the effectiveness of bisphosphonates on fractures and safety in transplant recipients and patients with chronic kidney disease.
https://immattersacp.org/weekly/archives/2017/04/11/4.htm
11 Apr 2017
Keep a close eye on the kidneys in diabetes
Screening and adherence to best prescribing practices offer two key ways to prevent or slow the progression of chronic kidney disease in patients with diabetes.
https://immattersacp.org/archives/2020/09/keep-a-close-eye-on-the-kidneys-in-diabetes.htm
1 Sep 2020
No association between antihypertensive treatment and mortality, CVD in mild, low-risk hypertension, but some association with increased adverse events
Physicians following guidelines that generalize findings from hypertension trials conducted in high-risk individuals to those at lower risk should use caution, the study authors noted.
https://immattersacp.org/weekly/archives/2018/11/06/5.htm
6 Nov 2018
MKSAP Quiz: follow-up visit for gout
A 55-year-old man is evaluated during a follow-up visit for gout. Two years ago, he had been treated with allopurinol and developed a hypersensitivity reaction. Over the past several months, he has had recurrent attacks of acute, episodic swelling of the first metatarsophalangeal joints with increasing involvement of other joints, including the ankles and knees. Laboratory studies showed significant hyperuricemia. History is also significant for Crohn disease, hypertension, chronic kidney disease (estimated glomerular filtration rate of 55 mL/min/1.73 m2), and nonalcoholic fatty liver disease. Current medications are diltiazem and azathioprine, which he has been taking for the past 9 months. Which of these is a contraindication to the use of febuxostat in this patient?
https://immattersacp.org/weekly/archives/2017/01/24/3.htm
24 Jan 2017
IDSA issues new clinical practice guideline for outpatient parenteral antimicrobial therapy
The new guideline updates 2004 recommendations from the Infectious Diseases Society of America (IDSA) with evidence from recent research, particularly on the safety of outpatient parenteral therapy.
https://immattersacp.org/weekly/archives/2018/11/20/5.htm
20 Nov 2018
Intensive blood pressure lowering may not induce true kidney disease
The findings can help improve understanding of the significance of creatinine elevations observed during hypertension therapy.
https://immattersacp.org/weekly/archives/2018/10/23/1.htm
23 Oct 2018
Anticonvulsant may increase mortality risk when coprescribed with opioids
An association was found between concomitant exposure to pregabalin in the preceding 120 days and significantly increased odds of opioid-related death versus exposure to opioids alone, a study found.
https://immattersacp.org/weekly/archives/2018/08/21/4.htm
21 Aug 2018